Cardiology News and Research

Latest Cardiology News and Research

Antihypertensive drugs may protect against COVID-19 in heart patients

Common drugs used in high blood pressure, heart failure, and diabetic patients with kidney damage, including angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), could be protective in patients with COVID-19.

31 Mar 2020

FDA to trial malaria drugs Chloroquine and Hydroxychloroquine for COVID-19

The U.S. Food and Drug Administration (FDA) this week provided the necessary authorization for clinical trials of chloroquine and hydroxychloroquine for the treatment of the novel coronavirus. These two drugs have been claimed by President Donald Trump to be a potential treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19 disease. To date, there has been no conclusive proof regarding the safety and efficacy of these drugs in COVID-19 cases, say officials.

31 Mar 2020

Total-body PET provides suitable images of antibodies up to 30 days after injection

Combining 89Zr-labeled antibodies with total-body positron emission tomography (PET) has extended the utility of novel total-body PET scanners, providing suitable images up to 30 days after the initial injection.

31 Mar 2020

Study reveals how hormone leptin contributes to weight loss

Some call it baby fat. But recent research has shown that adults have it too--which is a good thing. Brown fat, the so-called good fat that can protect against obesity and associated health risks, like cardiovascular disease and diabetes, is located in small pockets throughout the body.

31 Mar 2020

Location of broken bone in older people can have major impact on long-term health outcomes

In older individuals, the location of a broken bone can have significant impacts on long-term health outcomes, according to research accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.

31 Mar 2020

Three Australian experts explain the course of COVID-19

Researchers have been studying the ongoing pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) closely since its beginning in December 2019. To date, the virus has infected over 850,000 individuals across the globe and killed over 41,000.

31 Mar 2020

Mobile health devices effective in reducing AF-related adverse events, study finds

A new study, published in the Journal of the American College of Cardiology, highlights the feasible use of mobile health (mHealth) devices to help with the screening and detection of a common heart condition.

31 Mar 2020

People working long hours more likely to have hypothyroidism

Adults who work long hours are more likely to have hypothyroidism, which is an underactive thyroid, according to study results accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.

31 Mar 2020

Two newer types of diabetes medications show heart and kidney benefits

Two newer types of medications commonly used to treat type 2 diabetes are similar in their ability to reduce major heart complications, including heart attack, stroke and death from cardiovascular disease, according to research accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.

31 Mar 2020

Men with erectile dysfunction have higher risk of death, study suggests

Men with erectile dysfunction have a higher risk of death, regardless of their testosterone levels, suggests a study accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.

31 Mar 2020

Machine learning can help predict future diabetes patients

A type of artificial intelligence called machine learning can help predict which patients will develop diabetes, according to an ENDO 2020 abstract that will be published in a special supplemental section of the Journal of the Endocrine Society.

31 Mar 2020

Sheltered at home, families broach end-of-life planning

Long before she contracted COVID-19 at a Kirkland, Washington, nursing home, Barbara Dreyfuss made sure to document the wishes that would govern how she died.

31 Mar 2020

New 3D bioprinting technologies to create cardiovascular tissue

Cardiovascular disease is the leading cause of death worldwide, with over 17 million per year according to the World Health Organization.

From IDTechEx Ltd 31 Mar 2020

Horizon Discovery and Pharmahungary report positive early-stage results for novel micro-RNA therapeutic for ischemic heart diseases

Horizon Discovery Group plc and Pharmahungary Group announced positive early-stage results for a novel micro-RNA therapeutic for ischemic heart diseases.

31 Mar 2020

Working too many hours may lead to an underactive thyroid

A new study has found that people who work longer hours are more likely to have an underactive thyroid or hypothyroidism.

31 Mar 2020

Should you bring mom home from assisted living during the pandemic?

Dr. Alison Webb took her 81-year-old father out of assisted living, to live.

31 Mar 2020

Evinacumab drug reduces cholesterol levels in patients with rare cholesterol disorder

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled trial of the drug, which is being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

31 Mar 2020

Ticagrelor therapy, without aspirin, can benefit patients with acute coronary syndrome

Patients with acute coronary syndrome (ACS) who stopped taking aspirin three months after the insertion of a coronary stent and then took the anti-platelet medication ticagrelor alone for nine months had fewer episodes of bleeding and no increase in heart attacks, stroke or other adverse events caused by blockages in the arteries, compared with patients who took both aspirin and ticagrelor for a year.

31 Mar 2020

Why do men stop treatment for erectile dysfunction?

A new study published in the journal IJIR: Your Sexual Medicine Journal in March 2020 reports the most common reasons why men stop their treatment for erectile dysfunction. The most common reasons were that the treatment did not work, cost too much, or had unacceptable side effects. Loss of interest in sexual relationships was another primary reason.

31 Mar 2020

How to boost your immune system to fight coronavirus

As the world struggles with the coronavirus pandemic, more and more people are trying to protect themselves against the virus by all means possible. There are currently no vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), so boosting the immune system by way of diet, regular exercise, and sleep are sensible measures.

31 Mar 2020

Cardiology News and Research

Latest Cardiology News and Research

Antihypertensive drugs may protect against COVID-19 in heart patients

FDA to trial malaria drugs Chloroquine and Hydroxychloroquine for COVID-19

Total-body PET provides suitable images of antibodies up to 30 days after injection

Study reveals how hormone leptin contributes to weight loss

Location of broken bone in older people can have major impact on long-term health outcomes

Three Australian experts explain the course of COVID-19

Mobile health devices effective in reducing AF-related adverse events, study finds

People working long hours more likely to have hypothyroidism

Two newer types of diabetes medications show heart and kidney benefits

Men with erectile dysfunction have higher risk of death, study suggests

Machine learning can help predict future diabetes patients

Sheltered at home, families broach end-of-life planning

New 3D bioprinting technologies to create cardiovascular tissue

Horizon Discovery and Pharmahungary report positive early-stage results for novel micro-RNA therapeutic for ischemic heart diseases

Working too many hours may lead to an underactive thyroid

Should you bring mom home from assisted living during the pandemic?

Evinacumab drug reduces cholesterol levels in patients with rare cholesterol disorder

Ticagrelor therapy, without aspirin, can benefit patients with acute coronary syndrome

Why do men stop treatment for erectile dysfunction?

How to boost your immune system to fight coronavirus

Innovation in neuroscience drug discovery - eBook eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cardiology News and Research

Latest Cardiology News and Research

Innovation in neuroscience drug discovery - eBook eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in